GPT and fatty liver disease: Statistically significant differences among groups were found with respect to the following variables: (1) the anthropometric parameters such as age, gender, SBP, DBP, and BMI; (2) the inflammatory markers such as platelets and WBC; (3) the biomarker of liver damage, e.g., ALT, AST, and GGT; (4) the biochemical indicators such as FPG, creatinine, TC, TG, HDL-C, and LDL-C; (5) the indicator of hepatic steatosis such as HSI; (6) the indicator of hepatic fibrosis, NFS, for example, see Figure 2.